Resource data sheet
DNA Bank Top
Please review the QC test results indicated by check icon below as well as clone information before placing your order.

pGL4-phAPOE (#RDB07556)

Promoter collection, Human APOE promoter

Alternative name U2839-30
Clone info. PCR amplified human APOE promoter sequence was inserted into a firefly luciferase vector. Cloned fragment: 44904368 to 44905816(NC_000019.10); relatively -1428 to +21, where +1 corresponds to 1 nt of NM_001302688.2.
Comment PCR cloning, forward primer: CCTTGCCAGCCAAAGCAAAC; reverse primer: ACCTCCGCTGGGGCTGAGTA. Entire sequence of promoter region has not been confirmed.
Vector backbone pGL4.10 [Luc2] (Plasmid)
Selectable markers Amp^r
Gene/insert name Human apolipoprotein E genomic DNA
Depositor|Developer DNA Bank, |
 
Remarks, protocol and/or map (pdf) RDB07556.pdf

Distribution information

Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms
Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ]
MTA, for use for not-for-profit academic purpose [Word] [Example of MTA ]
Please visit Information of Request for Distribution.[link] 
Terms and conditions for distribution In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested.
Additional terms and conditions:
The use of the BIOLOGICAL RESOURCE is restricted to the academic researches conducted by non-profit organization. By using this material, the RECIPIENT agrees to be bound by the conditions of the limited use statement of the Promega Corporation.
提供案内 (日本国内) [open/close]

必要書類
提供依頼書  [依頼書の記入例 ]
提供同意書 (MTA, 非営利学術目的用)[Word] [MTAの記入例 ]
手続きの概要は、「提供申込みについて[link]」をご覧ください。
MTAに書く使用条件 謝辞の表明を必要とする。
MTAに書く付加的使用条件:
本件リソースの使用は学術機関での学術研究に限る。本件リソースの使用にあたって、利用者はプロメガ社の限定使用条件に従う必要がある。

Catalog # Resource name Shipping form Fee (non-profit org.)
RDB07556 pGL4-phAPOE DNA solution

Please review the QC test results indicated by check icon below as well as clone information before placing your order.

How to cite this biological resource

Materials & Methods section:

The pGL4-phAPOE was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB07556).

Reference section:

Further references such as user reports and related articles (go to bottom)


QC test results

RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by check icon as well as clone information before placing your order.

Test sheet RDB07556_A7Eop1.pdf check

Nucleotide sequence of a portion of this resource (if available).

Primer: pGL4-4174F
Sequence file: RDB07556_A7Eoa.seq check
>07556_07556_A7Eo_pGL4-4174F_A01_01_ABI08.ab1
    1 AAAGGGTCAA ACTTTCTCTG GCCTAACTGG CCGGTACCTG AGCTCGCTAG CCTCGAGGAT
   61 CCTTGCCAGC CAAAGCAAAC AGGCCCGGCC CGGCACTGGG GGTTCCTTCT CGAACCAGGA
  121 GTTCAGCCTC CCCTGACCCG CAGAATCTTC TGATCCCACC CGCTCCAGGA GCCAGGAATG
  181 AGTCCCAGTC TCTCCCAGTT CTCACTGTGT GGTTTTGCCA TTCGTCTTGC TGCTGAACCA
  241 CGGGTTTCTC CTCTGAAACA TCTGGGATTT ATAACAGGGC TTAGGAAAGT GACAGCGTCT
  301 GAGCGTTCAC TGTGGCCTGT CCATTGCTAG CCCTAACATA GGACCGCTGT GTGCCAGGGC
  361 TGTCCTCCAT GCTCAATACA CGTTAGCTTG TCACCAAACA TACCCGTGCC GCTGCTTTCC
  421 CAGTCTGATG AGCAAAGGAA CTTGATGCTC AGAGAGGACA AGTCATTTGC CCAAGGTCAC
  481 ACAGCTGGCA ACTGGCAGAG CCAGGATTCA CGCCCTGGCA ATTTGACTCC AGAATCCTAA
  541 CCTTAACCCA GAAGCACGGC TTCAAGCCCC TGGAAACCAC AATACCTGTG GCAGCCAGGG
  601 GGAGGTGCTG GAATCTCATT TCACATGTGG GGAGGGGGCT CCCCTGTGCT CAAGGTCACA
  661 ACCAAAGAGG AAGCTGTGAT TAAAACCCAG GTCCCATTTG CAAAGCCTCG ACTTTTAGCA
  721 GGTGCATCAT ACTGTTCCCA CCCCTCCCAT CCCACTTCTG TCCAGCCGCC TAGCCCCACT
  781 TTCTTTTTTT TCTTTTTTTG AGACAGTCTC CCTCTTGCTG AGGCTGGAGT GCAGTGGCGA
  841 GATCTCGGCT CACTGTAACC TCCGCCTCCC GGGTTCAAGC GATTCTCCTG CCTCAGCCTC
  901 CCAAGTAGCT AGGATTACAG GCGCCCGCCA CCCACGCCTG GCTAAACTTT TGTATTTTTT
  961 AGTAGAGATG GGGGTTTCAC CATGTTTGGC CCAGGCTGGT CTCAAACTCC TGACCCTTTA
 1021 AGTGATTTCG CCCACTGTTG CCTCCCAAAG TGCTGGGATA CAGCGTGAGC TACGTCCCCA
1081 GGCCCTCCAA TTCCCCACTT CCTTGTTCAA GGACTGT
//
Primer: pGL4-136R
Sequence file: RDB07556_A7Eob.seq check
>07556_07556_A7Eo_pGL4-136R_B01_02_ABI08.ab1
    1 GCTCTTATTG GTTTTTGGCA TCTTCCATGG TGGCTTTACC AACAGTACCG GATTGCCAAG
   61 CTTGGCCGCC GAGGCCAGAT CTTGATACCT CCGCTGGGGC TGAGTAGGAC TCAAGGATCC
  121 CAGACTTGTC CAATTATAGG GCTCCCCCTG TCCCGCCCCC TCCCCCAGGG ATAGGGCGGG
  181 CTGGGCCAGC CCCCAGTCAC GAGGTGGGCT GTTCTCCCCC TGCCCCAGGC ACAGCAGGGC
  241 AGAGGGAGGA AGGAGGTGGG GCATAGAGGT CTTTTGACCA CCCCCCACAG TCCCCAGGAA
  301 GGGAGGACAC CTCGCCCAGT AATACAGACA CCCTCCTCCA TTCTGGGGGC CAAGCGTGGA
  361 AGGGGAATGT GGAGGCTGCC GCCCAGAGTC CTCCTTTCCT GACCCTGTCC TTTCCTGTGC
  421 CTGGATGAAT GTAATCTGGA GAGGGGGCTG GGGATCTGGA CTCCTGGATC CCAGAAAGAA
  481 AGTAGGGCTA GGGGGCTGGA CAGAAGTGGG ATGGGAGGGG CTGGGGGCGG TAGCTCACGC
  541 CTGTAATCCC AGCACTTTGG GAGGCCACAG TGGGCGAATC ACTTAAGGTC AGGAGTTTGA
  601 GACCAGCCTG GCCAACATGG TGAAACCCCA TCTCTACTAA AAATACAAAA GTTAGCCAGG
  661 CGTGGTGGCG GGCGCCTGTA ATCCTAGCTA CTTGGGAGGC TGAGGCAGGA GAATCGCTTG
  721 AACCCGGGAG GCGGAGGTTA CAGTGAGCCG AGATCTCGCC ACTGCACTCC AGCCTCAGCA
  781 AGAGGGAGAC TGTCTCAAAA AAAGAAAAAA AAGAAAGTGG GGCTAGGCGG CTGGACAGAA
  841 GTGGGATGGG AGGGGTGGGA ACAGTATGAT GCACCTGCTA AAAGTCGAGG CTTTGCAAAT
  901 GGGACCTGGG TTTTAATCAC AGCTTCCTCT TTGGTTGTGA CCTTGAGCAC AGGGGAGCCC
  961 CCTCCCCCAC ATGTGAATGA GATTTCCAGC CACCCTCCCC CTGGCTGCCA CAGGTAATTG
 1021 TGCTTCCAAG GGACTGAGCC GTGCTTCTGG TAGGTAAGAA TCTGAGTCCA ATTGCAGGCG
1081 TGATCCTGGC CTCCCTGCCA GATGC
//
Primer: pAxCALNL_F1
Sequence file: RDB07556_A7Eoc.seq check
>07556_07556_A7Eo_pAxCALNL_F1_C01_03_ABI08.ab1
    1 TTTAATTGTT ATCTTTATCA TGTCTGCTCG AAGCGGCCGG CCGCCCCGAC TCTAGAATTA
   61 TTACACGGCG ATCTTGCCGC CCTTCTTGGC CTTAATGAGA ATCTCGCGGA TCTTGCGGGC
  121 GTCCAACTTG CCGGTCAGTC CTTTAGGCAC CTCGTCCACG AACACAACAC CACCGCGCAG
  181 CTTCTTGGCG GTTGTAACCT GGCTGGCCAC ATAGTCCACG ATCTCCTTCT CGGTCATGGT
  241 TTTACCGTGT TCCAGCACGA CGACTGCGGC GGGCAGCTCG CCGGCATCGT CGTCGGGCAG
  301 GCCGGCGACC CCGGCGTCGA AGATGTTGGG GTGTTGCAGC AGGATGCTCT CCAGTTCGGC
  361 TGGGGCTACC TGGTAGCCCT TGTATTTGAT CAGGCTCTTC AGCCGGTCCA CGATGAAGAA
  421 GTGCTCGTCC TCGTCCCAGT AGGCGATGTC GCCGCTGTGC AGCCAGCCGT CCTTGTCGAT
  481 GAGAGCGTTT GTAGCCTCGG GGTTGTTAAC GTAGCCGCTC ATGATCATGG GGCCACGGAC
  541 GCACAGCTCG CCGCGCTGGT TCACACCCAG TGTCTTACCG GTGTCCAAGT CCACCACCTT
  601 AGCCTCGAAG AAGGGCACCA CCTTGCCTAC TGCGCCAGGC TTGTCGTCCC CTTCGGGGGT
  661 GATCAGAATG GCGCTGGTTG TTTCTGTCAG GCCGTAGCCC TGGCGGATGC CTGGTAGGTG
  721 GAAGCGTTTG GCCACGGCCT CACCTACCTC CTTGCTGAGC GGCGCCCCGC CGCTGGCGAT
  781 CTCGTGCAAG TTGCTTAGGT CGTACTTGTC GATGAGAGTG CTCTTAGCGA AGAAGCTAAA
  841 TAGTGTGGGC ACCAGCAGGG CAGATTGAAT CTTATAGTCT TGCAAGCTGC GCAAGAATAG
  901 CTCCTCCTCG AAGCGGGTAC ATGAGCACGA CCCGAAGCCG CAGATCAAGT AGCCCAGCGT
  961 GATGAACATG CCGGAAGCCG TGGTGAAATG CACCACGCTG AGGATAGCGG TGTTCGGGAT
 1021 GATCTGGGTT GGCCGGAGAT GGTGTTCGCG GTCCATGGAC CTGAATTCGA CCAGCGAGGC
1081 GCATGCGGTT AGGCCTACGG CCTC
//

Please visit Sequencing and PCR primers for primer information.


References

Original, user report and related articles